INTRODUCTION
Diabetes mellitus presents a significant global health burden, with more than half a billion adults living with the condition in 2024.1 There are many long-term complications of diabetes, including foot deformities and ulceration. Foot ulcers and infections precede approximately 80% of major lower-extremity amputations.2 The physical, psychological, and socioeconomic impacts associated with diabetes-related amputations emphasize the importance of robust clinical pathways for limb preservation.3 Studies show that multidisciplinary teams, comprising specialties such as family or hospital medicine, endocrinology, infectious disease, wound care, podiatry, and vascular surgery, reduce major amputations.3,4 This collaborative model is not just about managing a complex disease; it is a vital strategy that actively improves patient outcomes and prevents irreversible limb loss that is predicted to affect 783 million people by 2045.1
DEFINITION AND STRUCTURE OF A MULTIDISCIPLINARY LIMB-PRESERVATION TEAM
People with diabetic foot ulcers (DFUs) often face fragmented clinical care, despite a coordinated multidisciplinary approach being known to improve limb amputation rates by up to 60%.5 Multidisciplinary teams benefit from the involvement of numerous specialists, with the podiatrist and vascular surgeon (ie, the “toe and flow”) anchoring teams owing to their ability to rapidly diagnose and address structural deficits, wounds, and ischemia.6
Podiatry
Podiatrists play an essential role in treating foot deformities and soft tissue complications linked to diabetes to prevent amputations. The prevention strategy includes regular foot examinations, consistent wound debridement, and an evaluation of how to offload the wound.7,8 Surgical offloading methods, such as exostectomy or reconstruction, can be powerful tools that treat the wounds, prevent reoccurrence, and also keep Charcot neuroarthropathy at bay. Nonsurgical methods and collaboration with a prosthetic/orthotic team ensure the patient consistently uses assistive devices to achieve consistent wound pressure relief. In addition, stagnant wounds may benefit from aggressive and frequent wound debridement or the application of skin substitutes. These options are continuously reevaluated, and podiatrists must have a watchful eye and be willing to find new strategies when needed for offloading, effective wound healing, and surveillance to prevent reulcerations.
Vascular Surgery
Approximately half of all patients with a DFU will also suffer from peripheral artery disease (PAD), often manifesting in the most severe form: chronic limb-threatening ischemia (CLTI). The vascular surgeon’s role is to establish the severity of the arterial occlusive disease and determine when revascularization is required for healing a neuroischemic wound. Strong physical examination skills and access to noninvasive imaging using arterial duplex and ankle/brachial indices with toe pressures are the bedrock of this approach, and a peripheral vascular laboratory is an essential component for the vascular surgeon in the limb-preservation setting. Angiography is often the next step in patients with CLTI, depending on the extent of their ischemia and the size of their wound. These determinations are guided by the Society for Vascular Surgery (SVS) wound, ischemia, foot infection (WIfI) classification system, which is focused on WIfI categories to best determine the risk of limb amputation and potential benefit of revascularization (Fig. 1).9
Fig. 1.

SVS WIfI Classification System predicts major amputation risk and benefit of revascularization. TCPO2, transcutaneous partial pressure of oxygen. (**Reprinted with permission from Dr. David Armstrong from https://diabeticfootonline.com/2015/04/02/visualizing-and-using-wifi-everyday-wound-ischemia-foot-infection-three-dynamic-rings-of-risk/.)
The vascular surgeon must communicate regularly with the podiatrist to discuss what revascularization options are possible and to determine the timeline of definitive foot reconstruction status post revascularization. This is because not all target arteries can be revascularized, and there are certain revascularizations that are at higher risk for earlier failures than others. This is especially important when considering complex revascularization procedures, such as deep venous arterialization, which often require frequent reinterventions and intensive wound care. Finally, when the podiatrist identifies that a wound, or a reconstruction, is showing signs of delayed healing or worsening ischemia, they should immediately be in contact with their vascular surgery partner to allow them to reassess the blood flow and determine if additional interventions are possible.
Infectious Disease
Although not co-captains of the espoused toe and flow model, infectious disease clinicians serve a vital role on the multidisciplinary team.10–12 Their expertise is especially impactful for cases involving osteomyelitis or deep space abscess. In these instances, infectious disease clinicians excel at providing information about the potential success of medical therapy alone, or in conjunction with a more proximal amputation. Because of their training in internal medicine, they are often the best team members to explain how factors like glycemic control, smoking cessation, and other medical comorbidities contribute to the risk of amputation. This is an important preamble to the role of a hospitalist or endocrinologist, gauging patient readiness and priming them for further discussions.
Hospitalist Medicine
Although limb-preservation teams were originally formed around surgical subspecialties, given the significant comorbidities that often accompany diabetes mellitus and PAD, there are increasing recommendations for general internist participation during the inpatient care received in the perioperative periods around vascular and/or podiatric surgery. A systematic review of multidisciplinary limb-preservation teams from 2020 demonstrated that general internists were present on 30% of teams at that time, and it is reasonable to expect this number to grow given increasing medical complexity of inpatients and emphasis on care coordination and quality improvement.12
PATIENT-CENTERED BENEFITS OF A MULTIDISCIPLINARY TEAM
The patient is the central focus of any multidisciplinary limb-preservation program. Although professional collaboration is vital, the ultimate success of these efforts is determined by patient understanding, engagement, and well-being. A team-based approach offers significant benefits in three interconnected domains: treatment adherence, health education, and quality of life.
Adherence to treatment is a frequent barrier, particularly for patients facing mobility, transportation, or financial challenges. In this setting, alignment of appointments and comprehensive follow-up can meaningfully affect outcomes. For example, a multidisciplinary foot clinic in England with co-scheduled appointments with multiple specialists reduced major amputations (2.5% vs 11%; P=.04) compared with podiatry-only care.13 Meta-analyses of randomized and observational studies report marked reductions in major and minor amputations, shorter time to heal, and improved survival when compared with nonteam models.14 This suggests that aligned messaging across specialties, where podiatrists, vascular surgeons, and infectious disease specialists reinforce key care principles, can directly impact clinical outcomes.
There is a significant gap in the understanding of the quality of life experienced by people at risk of limb loss, and very few studies report on this outcome.13 There is ongoing work being done by professional organizations to develop disease-specific core outcome sets that include patient-reported outcomes.15 Validated instruments like the recently developed diabetic foot patient–reported outcome scale demonstrate acceptable reliability and validity in capturing patient perspectives.16 The multicenter Diabetes-Related Extremity Amputation Depression and Distress study highlights the profound emotional impact of limb-threatening disease and amputation risk; greater than 40% of patients with diabetes facing major amputation reported clinically significant depressive symptoms, and greater than 50% experienced diabetes-specific distress directly tied to fear of limb loss.17 Broader quality-of-life measures show that coordinated care improves functional outcomes and satisfaction among patients with diabetic foot pathologic condition.18 Multidisciplinary care teams that incorporate quality-of-life measures and mental health support are likely better positioned to improve engagement, reduce anxiety, and ultimately strengthen adherence and outcomes.
CLINICAL BENEFITS OF A MULTIDISCIPLINARY TEAM
Podiatry
Podiatry occupies a central role in multidisciplinary limb-preservation programs, often serving as the first point of contact for patients with foot complications and as a continuous thread throughout care. This integrative role bridges care between disciplines and ensures patients receive a seamless and unified treatment plan.6,19
Core responsibilities include wound care, surgical and nonsurgical debridement, application of skin substitutes, biomechanical assessment, pressure offloading, and prescription of orthotic devices.19,20 Sharp debridement remains the standard of care and should be repeated frequently as needed.21 Coupled with advanced dressings, these techniques promote optimal healing environments. To maintain that environment, offloading is arguably the most critical intervention for healing, especially for plantar ulcers.6 The 2023 International Working Group on the Diabetic Foot strongly recommends nonremovable knee-high offloading devices as the first-line option.22 Meta-analyses demonstrate that total contact casting (a nonremovable device) yields faster healing and higher closure rates compared with removable devices.23
Beyond wound care, podiatrists assess structural and biomechanical contributors to recurrent ulceration. Identification of deformities, gait abnormalities, and focal pressure points enables targeted interventions that reduce the risk of future breakdown. Surgical contributions range from tendon lengthening to partial foot reconstruction, each undertaken with the goal of maintaining limb function.20
Vascular Surgery
PAD is present in up to 50% of patients with DFUs and is strongly associated with delayed healing, infection, and above-ankle amputation.20,24 In CLTI, revascularization restores pulsatile arterial flow, improves tissue perfusion, and reduces the risk of both amputation and mortality.25,26 Neuroischemic DFU represents the most severe presentation, and outcomes are closely related to the timeliness of revascularization.27,28 The Vascular Society for Great Britain and Ireland published best-practices guidelines for PAD management in March 2019, updated in 2022.29,30 The Peripheral Arterial Disease Quality Improvement Framework set time targets of no more than two days from referral to admission, no more than twelve hours from admission to cross-sectional imaging, no more than fourteen hours to vascular evaluation, and no more than five days to revascularization after admission.30 Although meeting these benchmarks can be challenging, particularly in systems without existing multidisciplinary teams or regions with limited vascular specialist availability, these recommendations highlight the critical importance of minimizing delays to revascularization.28,29 Coordinated planning between podiatrists and vascular specialists aligns the timing and durability of revascularization with wound management and foot procedures, while also expediting referrals, streamlining diagnostic imaging, and ensuring rapid treatment of patients with CLTI. Beyond limb-related outcomes, this integrated model can improve wound healing, enhance quality of life, and reduce hospitalizations and overall costs of care.
Infectious Disease
Infectious disease clinicians are experts in interpreting the results of deep tissue and bone cultures, especially when there is concern that prior antibiotics might impact culture yield.31 A second important contribution is the determination of whether an infection can be managed with antibiotics alone, or by surgical removal of bone (with or without postoperative antibiotics). There is no single, best answer to this question, and decision-making is highly nuanced.32 Surgeons provide expertise on the feasibility of complete resection and its impact on function,33,34 while infectious disease clinicians offer opinions about the probability of a cure with medical management alone. Together, a medical-surgical approach might lead to a more distal amputation with subsequent antibiotics for residual infection and a better long-term, functional outcome.35,36
Hospitalist Medicine
Patients with CLTI often also have clinically significant cardiovascular disease and, thus, have a ten- to fifteen-fold increased risk of cardiovascular death compared with patients without PAD, as well as an increased risk of major adverse limb events after revascularization.37 These comorbidities, deemed risk amplifiers, include diabetes mellitus, chronic kidney disease/end-stage renal disease, polyvascular disease (defined as the presence of atherosclerosis in two or more vascular beds), tobacco abuse, and depression.38
Unfortunately, more than two-thirds of patients with CLTI do not have medically controlled comorbidities, resulting in up to an eight-fold risk of major amputation and/or death.39 Given this, inpatient admissions are an opportune time to ensure patients are on appropriate, guideline-directed medical therapy. This includes inpatient monitoring of lipids, hemoglobin A1c, and smoking as well as initiation and titration of lipid-lowering, antihypertensive, and smoking cessation medications as appropriate. Antiplatelet and antithrombotic medication decisions are often left to the vascular specialists.
Poor glycemic control has an exponential effect on risk of major adverse cardiac events with the EUCLID trial noting a 14.2% increased risk for every 1% increase in hemoglobin A1c.40 Teams should have a low threshold to involve endocrinology providers for patients with uncontrolled diabetes to help manage inpatient hyperglycemia and to develop comprehensive, individualized patient care plans that include not only pharmacotherapy but also diet and exercise in order to help patients achieve long-term improved glucose control.
SYSTEMS-LEVEL BENEFITS
Multidisciplinary limb teams consistently demonstrate value by decreasing the rate of major amputations, which are very financially burdensome to health systems, by 39% - 56%.11,12,41 In addition, care pathways containing stepwise protocols ensure expedited, evidenced-based care that can shift care to less costly outpatient offices and avoid emergency department visits and urgent inpatient hospitalizations.41
Once admitted to a hospital, the effects of multidisciplinary care on length of stay and readmission rates are less well defined, but some small studies indicate that it is possible to have a decrease in hospital days and decrease in time to definitive, surgical management.42–44 Given that 30-day readmission rates for patients with DFU and/or CLTI are as high as 30%, this is a prime area to focus quality- and value-based care initiatives.45–47
There is currently a paucity of data on whether multidisciplinary limb-preservation teams result in direct cost savings for US health care organizations; however, hospitalizations for nontraumatic major amputations cost $53,700 per hospitalization (2010 data).48 Measuring the financial benefits of multidisciplinary limb-preservation teams by predicting the “number of limbs saved” is both a patient-centered and cost-effective approach.
CASE STUDY
An 82-year-old woman with PAD, aortic dissection treated with thoracic endograft, diabetes controlled with oral medications, and tobacco abuse presented to the emergency department with a posterior ankle wound that had worsened over 2 months (Fig. 2). Vascular surgery consult noted that she did not have a femoral pulse nor did she have adequate perfusion to heal her wound (Fig. 3; Ankle-brachial index, 0; toe pressure, 33 mm Hg). The patient underwent computed tomographic angiography, and an iliac occlusion was identified with moderate multifocal tibial stenosis. Podiatric examination revealed that the wound involved the Achilles tendon, which helped frame the complexity of the patient’s issue. Based on SVS WIfI classification, the patient was a W 2, I 3, fI 0—clinical stage 4 disease, with a high risk of amputation and high potential benefit for revascularization. At this point, the patient was admitted to the authors’ hospitalist-run threatened limb service for rapid risk stratification and medical optimization for blood pressure control before proceeding to the operating room for a joint vascular and podiatry case. The patient underwent a femoral-to-femoral bypass, wound debridement, bilayer skin substitute placement (Fig. 4), ankle immobilization and off-loading. The hospitalist service continued to adjust antihypertensive medications and her statin; assessed nutritional status and added relevant dietary supplements; coordinated with the infectious disease specialist to determine that a 2-week course of oral antibiotics would be sufficient based on intraoperative data; and ensured a smooth transition to a skilled nursing facility, as the patient could not be safely discharged home with her non-weight-bearing status. One month post procedure, she had joint vascular and podiatry clinic visits. Noninvasive vascular studies were obtained, which demonstrated a significant improvement in perfusion (ABI, 0.9; toe pressure, 61), and the top layer of the skin substitute was removed, revealing granulation tissue forming over the remaining scaffold layer (Fig. 5). Two weeks later, a split-thickness skin graft was applied, and at three months, she was fully healed and starting physical therapy (Fig. 6).
Fig. 2.

Right posterior distal leg wound. (A) Wound appearance at initial urgent care presentation. (B) Wound appearance 2 months later in the threatened limb clinic.
Fig. 3.

Baseline noninvasive vascular assessment. BP, blood pressure; Dor. Pedis (DP), dorsalis pedis; L, left; Post Tibial (PT), posterior tibial; R, right; TBI, toe-brachial index.
Fig. 4.

Right posterior leg wound after debridement and skin substitute placement.
Fig. 5.

Right leg wound healing after 1 month. (A) Bilayer skin substitute in place. (B) Silicone layer of skin substitute removed.
Fig. 6.

Right posterior leg wound healed after split-thickness skin grafting.
Some key elements of this case are the importance of communication between vascular and podiatry colleagues. Achilles wounds are very challenging, and the insight that the podiatry partner provided was extremely helpful for avoiding a lag between her revascularization and debridement and immobilization, which were vital to her healing. Regarding her perfusion, the femoral-femoral bypass provided adequate perfusion for wound healing; however, given that the patient did have disease at multiple levels, if wound healing stalled at any point, additional revascularization would have been done. The team was particularly watchful for adequate perfusion before her final skin grafting. The hospitalist team ensured that the patient’s overall medical stability and coordinated discharge planning. Finally, the multidisciplinary outpatient clinic and weekly threatened limb clinical conferences allowed the authors to use a team approach, with the ability to communicate quickly and respond efficiently throughout the limb-preservation process.
BARRIERS TO MULTIDISCIPLINARY TEAM IMPLEMENTATION
Despite their clear benefits, multidisciplinary teams are challenging to implement, as they often require culture change and realignment of services to keep clinicians from multiple departments and practice settings united. Most multidisciplinary teams are based in urban, tertiary centers where vascular surgeons and infectious disease specialists are typically located10,49,50; however, informal alliances of clinicians outside of these settings can be formed to target geographic areas with health care access challenges. Transportation can be a problem for both rural patients and those in urban, disadvantaged neighborhoods.51–53 Telehealth can be useful but is not a viable option when hands-on care is necessary. Insurance coverage, disjointed electronic medical records, and poor triage pathways threaten to widen disparity gaps if equitable triage is not part of the implementation plan.54–56 With thoughtful design, however, these teams may be one of the best tools to combat disparities in limb salvage and improve outcomes for all.51,57
Once key clinicians are identified, multidisciplinary teams often can be established with existing resources.44,58,59 Many begin in either the inpatient or outpatient setting and then mature to span both, providing continuity of care.12 Implementation should focus on supporting collaboration within team members and between the team and referring clinicians; care algorithms that delineate clinicians’ roles are particularly useful.60 Clinicians within and outside the team benefit from stable partnerships and face-to-face interactions.61,62 For referring clinicians, an in-person introduction to a multidisciplinary team member and exchange of contact information may be all that is necessary to develop trusting, impactful partnerships.61,63 Clear and rapid triage systems, especially for those outside the team’s immediate health care system, should be a top priority.64–67
THE FUTURE
The approach to diabetic limb salvage is evolving from reactive to proactive, multidisciplinary care teams with the constant goals of prevention, avoiding disease progression and the worst complications. Proactive, coordinated models are making a noticeable difference by lowering the rates of major amputations and improving the overall well-being of patients.20 More professionals—including clinical pharmacists, therapists, and dietitians—are being brought in to strengthen both inpatient and outpatient services for patients facing limb threat.
Telehealth has emerged as an effective approach for managing DFUs, particularly in rural and underserved communities, where a significant number of people struggle to travel long distances for specialty care. In a study of 232 people examined over a twelve-week period, nurse-led telemedicine in rural hospitals achieved comparable rates of ulcer healing and amputations to those observed with traditional in-person wound and podiatric care.68,69
Custom-made offloading devices—such as tailored insoles and shoes—have shown greater effectiveness in reducing or preventing ulcer recurrence compared with standard, prefabricated alternatives.70–72 Emerging technologies, including smart insoles, wearable pressure sensors, and telemonitoring systems, offer promising avenues for enhancing offloading adherence.24,25 These advances to existing patient monitoring systems can provide regular data on wound healing, vital signs, and medical communication, enabling health care providers to address complications and intervene at earlier stages.68,69
Artificial intelligence (AI) and machine learning are playing a bigger role in managing DFUs and are bringing new possibilities for patient care.73 Predictive analytics can even use large patient data sets to identify high-risk patients, which may help prevent DFUs before they start.73 Additionally, these tools can help clinicians diagnose, treat, and predict how ulcers will heal on an individualized level based on each patient’s own longitudinal history.73 Thermogram-based classifiers and personalized offloading prescriptions support early detection and tailored treatment.73,74
Although these technological advances are already being used to improve outcomes, the basics will be as important as ever. Education and advocacy are still needed for raising awareness and focusing on prevention of diabetes and its complications. Strong patient education about daily foot checks, proper shoes, and keeping blood sugar under control will always be a cornerstone of care. A strong multidisciplinary limb-preservation team (whether in person, remote, or AI-assisted) to treat people with diabetes and foot deformities or ulcers will be the key to good outcomes.75,76
SUMMARY
The implementation of multidisciplinary limb-preservation teams represents a critical advancement in the management of diabetic foot disease and related complex pathologic conditions. By integrating the specialized expertise of podiatry, vascular surgery, infectious disease, endocrinology, and hospital medicine within coordinated care pathways, these models demonstrate measurable improvements in limb preservation, functional outcomes, and overall survival. Sustained commitment to interdisciplinary collaboration, standardized protocols, and longitudinal follow-up is essential to further optimize outcomes and establish multidisciplinary limb-preservation programs, which can even be enhanced as the world moves closer to integrating many fields with AI-generated tools.
CLINICS CARE POINTS.
Assess and address real-world barriers to offloading.
Expedite vascular assessment starting with ankle- and toe-brachial indices.
When managing osteomyelitis complicating diabetic foot ulcers, consider both medical and surgical options, tailoring treatment to what maximizes function and quality of life for the patient in front of you.
Don’t forget to address factors proximal to the ankle: glycemic control, blood pressure, lipids, and smoking.
KEY POINTS.
Multidisciplinary limb-preservation teams integrate podiatry, vascular surgery, infectious disease, endocrinology, and family and hospital medicine to optimize care.
Coordinated inpatient and outpatient pathways with standardized protocols to promote early, proactive interventions, improve wound healing, reduce amputation risk, and enhance survival.
Patient-centered care models, with or without artificial intelligence–assisted devices, promote functional recovery, quality of life, and long-term disease management.
DISCLOSURES
D. Darji, K.E. Wamelink, F. Farber, M.B. Brennan, and T.-W. Tan have nothing to declare. K.L. McGinigle has received consultant fees from Medtronic, Inc, Vascular Technologies, Inc, and Shockwave Medical, Inc and has received research support from the Novo Nordisk Foundation and the National Heart, Lung, and Blood Institute (R01-HL179230, R21-HL172091). S.D. Minc declares support from National Institute of Diabetes and Digestive and Kidney Diseases (K23DK128569), and the Society of Vascular Surgery Foundation/American College of Surgeons. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Abbreviations
- AI
artificial intelligence
- CLTI
chronic limb-threatening ischemia
- DFU
diabetic foot ulcer
- PAD
peripheral artery disease
- SVS
Society for Vascular Surgery
- WIfI
wound, ischemia, foot infection
REFERENCES
- 1.Magliano DJ, Boyko EJ, Genitsaridi I, et al. , editors. IDF diabetes atlas. 11th edition. International Diabetes Federation; 2025. [Google Scholar]
- 2.Saeedi P, Petersohn I, Salpea P, et al. , IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. 10.1016/j.diabres.2019.107843. [DOI] [PubMed] [Google Scholar]
- 3.Armstrong DG, Tan TW, Boulton AJM, et al. Diabetic foot ulcers: a review. JAMA 2023;330(1):62–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ortiz-Zúñiga Á, Samaniego J, Biagetti B, et al. Impact of diabetic foot multidisciplinary unit on incidence of lower-extremity amputations by diabetic foot. J Clin Med 2023;12(17):5608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kayssi A, Minc S, Armstrong DG. In the know with toe and flow. Semin Vasc Surg 2025;38:1–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rogers LC, Andros G, Caporusso J, et al. Toe and flow: essential components and structure of the amputation prevention team. J Vasc Surg 2010;52. 23S–7S. [DOI] [PubMed] [Google Scholar]
- 7.Kim PJ, Attinger CE, Evans KK, et al. Role of the podiatrist in diabetic limb salvage. J Vasc Surg 2012;56(4):1168–72. [DOI] [PubMed] [Google Scholar]
- 8.Mrdjenovich DE. Off-loading practices for the wounded foot: concepts and choices. J Am Col Certif Wound Spec 2011;2(4):73–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mills JL Sr, Conte MS, Armstrong DG, et al. , Society for Vascular Surgery Lower Extremity Guidelines Committee. The Society for Vascular Surgery Lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220–34.e1–2. [DOI] [PubMed] [Google Scholar]
- 10.Brennan MB, Allen GO, Ferguson PD, et al. The association between geographic density of infectious disease physicians and limb preservation in patients with diabetic foot ulcers. Open Forum Infect Dis 2017;4(1):ofx015. 10.1093/ofid/ofx015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Albright RH, Manohar NB, Murillo JF, et al. Effectiveness of multidisciplinary care teams in reducing major amputation rate in adults with diabetes: a systematic review & meta-analysis. Diabetes Res Clin Pract 2020;161:107996. 10.1016/j.diabres.2019.107996. [DOI] [PubMed] [Google Scholar]
- 12.Musuuza J, Sutherland BL, Kurter S, et al. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg 2020;71(4):1433–46.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Phillips LA, Stewart D, McGill M, et al. Outcomes of a multidisciplinary foot clinic compared with podiatry-only care in NHS Fife: reduced amputation rates and improved healing. Diabet Med 2022;39(11):e14987. 10.1111/dme.14987. [DOI] [Google Scholar]
- 14.Meloni M, Izzo V, Giurato L, Uccioli L. Multidisciplinary team approach improves healing, reduces amputations and mortality in diabetic foot ulcers: a systematic review and meta-analysis. Acta Diabetol 2024;61(3):345–56. [Google Scholar]
- 15.Staniszewska A, Game F, Nixon J, et al. Development of a core outcome set for studies assessing interventions for diabetes-related foot ulceration. Diabetes Care 2024;47(11):1958–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wang X, Hu X, Que H. Development of patient-reported outcome scale for patients with diabetic foot and its reliability and validity test. Diabetes Metab Syndr Obes 2023;16:2921–7. Published 2023 Sep 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Brooks LM, Brooks BM, Arp AS, et al. Diabetes-related extremity amputation depression and distress (DREADD): a multimethod study. Semin Vasc Surg 2025;38(1):94–100. [DOI] [PubMed] [Google Scholar]
- 18.Rezaie W, Lusendi F, Doggen K, et al. Health-related quality of life in patients with diabetic foot ulceration: study protocol for adaptation and validation of patient-reported outcome measurements (PROMs) in Dutch-speaking patients. BMJ Open 2019;9(12):e034491. 10.1136/bmjopen-2019-034491. Published 2019 Dec 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the society for vascular surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016;63(2 Suppl):3S–21S. [DOI] [PubMed] [Google Scholar]
- 20.Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376(24):2367–75. [DOI] [PubMed] [Google Scholar]
- 21.International Working Group on the Diabetic Foot. IWGDF guidelines: sharp debridement as standard of care. E-Interventional Journal; 2023–2024. [Google Scholar]
- 22.Bus SA, Armstrong DG, Crews RT, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews, 40(3), e3647. International Working Group on the Diabetic Foot. (2023). Guidelines on offloading foot ulcers in persons with diabetes: IWGDF 2023 update (IWGDF-2023–06 Offloading Guideline) [PDF]. [DOI] [PubMed] [Google Scholar]
- 23.Fletcher J Total contact casting as “gold-standard” offloading and barriers to use. Wounds U K; 2023. [Google Scholar]
- 24.Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007;50(1):18–25. [DOI] [PubMed] [Google Scholar]
- 25.Farber A, Eberhardt RT. The current state of critical limb ischemia: a systematic review. JAMA Surg 2016;151(11):1070–7. [DOI] [PubMed] [Google Scholar]
- 26.Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022;387(25):2305–16. [DOI] [PubMed] [Google Scholar]
- 27.Elgzyri T, Larsson J, Nyberg P, et al. Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg 2014;48(4):440–6. [DOI] [PubMed] [Google Scholar]
- 28.Li Q, Birmpili P, Johal AS, et al. Delays to revascularization for patients with chronic limb-threatening ischaemia. Br J Surg 2022. znac109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Speirs TP, Atkins E, Chowdhury MM, et al. Adherence to vascular care guidelines for emergency revascularization of chronic limb-threatening ischemia. J Vasc Surg Cases Innov Tech 2023;9(4):101299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.A best practice clinical care pathway for peripheral arterial disease. jVascSocGBIrel 2022;1. 10.54522/jvsgbi.2022.017. [DOI] [Google Scholar]
- 31.Schechter MC, Ali MK, Risk BB, et al. Percutaneous bone biopsy for diabetic foot ostemyelitis: a systematic review and meta-analysis. Open Forum Infect Dis 2020;7(10):efaa393. 10.1093/ofid/ofaa393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tardáguila-García A, Sanz-Corbalán I, García-Alamino JM, et al. Medical versus surgical treatment for the management of diabetic foot osteomyelitis: a systematic review. J Clin Med 2021;10(6):1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.O’Hara LM, Lydecker AD, Robinson GL, et al. Understanding patient preferences regarding limb salvage for diabetic foot ulcers: a discrete choice experiment. Diabetes Care 2025;48(9):1517–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cach G, Rogers AE, Spoer DL, et al. Amputation acceptance: a survey of factors influencing the decision to undergo lower extremity amputation. J Foot Ankle Surg 2023;62(3):548–52. [DOI] [PubMed] [Google Scholar]
- 35.Svensson H, Apelqvist J, Larsson J, et al. Minor amputation in patients with diabetes mellitus and severe foot ulcers achieves good outcomes. J Wound Care 2011;20(6):261–2, 264, 266 passim. [DOI] [PubMed] [Google Scholar]
- 36.Wukich DK, Rspovic KM, Jupiter DC, et al. Amputation and infection are the greatest fears in patients with diabetes foot complications. J Diabet Complicat 2022; 36(7):108222. 10.1016/j.jdiacomp.2022.108222. [DOI] [PubMed] [Google Scholar]
- 37.Criqui MH, Ninomiya JK, Wingard DL, et al. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 2008;52:1736–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gornik H, Aronow H, Goodney P, et al. ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of Cardiology/American Heart Association Joint Committee on clinical practice Guidelines. JACC (J Am Coll Cardiol) 2024;83(24):2497–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chung J, Timaran DA, Modrall JG, et al. Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia. J Vasc Surg 2013;58:972–80. [DOI] [PubMed] [Google Scholar]
- 40.Low Wang CC, Blomster JI, Heizer G, et al. Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: the EUCLID trial. J Am Coll Cardiol 2018;72:3274–84. [DOI] [PubMed] [Google Scholar]
- 41.Meza-Torres B, Carinci F, Heiss C, et al. Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. Acta Diabetol 2021;58(6):735–47. Epub 2021 Feb 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lavery LA, Wunderlich RP, Tredwell JL. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005;70(1):31–7. Epub 2005 Mar 31. [DOI] [PubMed] [Google Scholar]
- 43.Manji A, Basiri R, Harton F, et al. Effectiveness of a multidisciplinary limb preservation program in reducing regional hospitalization rates for patients with diabetes-related foot complications. Int J Low Extrem Wounds 2025;24(1):117–23. Epub 2024 Mar 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Laakso M, Honkasalo M, Kiiski J, et al. Re-organizing inpatient care saves legs in patients with diabetic foot infections. Diabetes Res Clin Pract 2017;125:39–46 (REPEAT). [DOI] [PubMed] [Google Scholar]
- 45.Alahakoon C, Thanigaimani S, Seng L, et al. Editor’s choice - a systematic review and meta-analysis of the incidence and risk factors for Re-admission to Hospital in people with diabetes related foot disease. Eur J Vasc Endovasc Surg 2023;66(2):195–202. Epub 2023 May 13. [DOI] [PubMed] [Google Scholar]
- 46.Remington AC, Hernandez-Boussard T, Warstadt NM, et al. Analyzing treatment aggressiveness and identifying high-risk patients in diabetic foot ulcer return to care. Wound Repair Regen 2016;24(4):731–6. Epub 2016 Jun 8. [DOI] [PubMed] [Google Scholar]
- 47.Holscher CM, Hicks CW, Canner JK, et al. Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting. J Vasc Surg 2018;67(3):876–86. Epub 2017 Oct 7. [DOI] [PubMed] [Google Scholar]
- 48.Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg 2014;60(5):1247–54.e2. Epub 2014 Jun 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Potluri VK, Bilello JL, Patel SG, et al. Characterizing the geographic distribution of vascular surgeons in the United States. J Vasc Surg 2023;77(1):256–61. [DOI] [PubMed] [Google Scholar]
- 50.Fan KL, DeLia D, Black CK, et al. Who, what, where: demographics, severity of presentation, and location of treatment drive delivery of diabetic limb reconstructive services within the National Inpatient Sample. Plast Reconstr Surg 2020;145(6):1516–27. [DOI] [PubMed] [Google Scholar]
- 51.Campbell DB, Gutta G, Sobol CG, et al. How multidisciplinary clinics may mitigate socioeconomic barriers to care for chronic limb-threatening ischemia. J Vasc Surg 2024;80(4):1226–37.e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Vanesse LT, Chang HH, D’Souza R, et al. Spatial associations between measures of public transportation and diabetic foot ulcer outcomes in the state of Georgia: 2016–2019. BMJ Open Diabetes Res Care 2024;12(6):e004461. 10.1136/bmjdrc-2024-004461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mota L, Jayaram A, Wu WW, et al. The impact of travel distance in patient outcomes following revascularization for chronic limb-threatening ischemia. J Vasc Surg 2024;80(6):1766–75.e3. [DOI] [PubMed] [Google Scholar]
- 54.Sutherland BL, Pecanac K, Bartels CM, et al. Expect delays: poor connections between rural and urban health systems challenge multidisciplinary care for rural Americans with diabetic foot ulcers. J Foot Ankle Res 2020;13(1):32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.McPherson M, Carroll M, Stewart S. Patient-perceived and practitioner-perceived barriers to accessing foot care services for people with diabetes mellitus: a systematic literature review. J Foot Ankle Res 2022;15(1):92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tan TW, Crocker RM, Palmer KNB, et al. A qualitative study of barriers to care-seeking for diabetic foot ulceration across multiple levels of the healthcare system. J Foot Ankle Res 2022;15(1):56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Hicks CW, Canner JK, Mahioudakis N, et al. Neighborhood socioeconomic disadvantage is not associated with wound healing in diabetic foot ulcer patients treated in a multidisciplinary setting. J Surg Res 2018;224:102–11. [DOI] [PubMed] [Google Scholar]
- 58.Rerkasem K, Kosachunhanun N, Tongprasert S, et al. Reducing lower extremity amputations due to diabetes: the application of diabetic-foot protocol on Chiang Mai University Hospital. Int J Low Extrem Wounds 2008;7(2):88–92. [DOI] [PubMed] [Google Scholar]
- 59.Riaz M, Miyan Z, Waris N, et al. Impact of multidisciplinary foot care team on outcome of diabetic foot ulcer in term of lower extremity amputation at a tertiary care unit in Karachi, Pakistan. Int Wound J 2019;16(3):768–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Yong E, Gong H, Liew H, et al. Getting a foothold on diabetic foot disease-outcomes of a multidisciplinary clinical pathway for inpatient diabetic foot care: a 17-year institutional review. Int J Low Extrem Wounds 2025;24(1):177–85. [DOI] [PubMed] [Google Scholar]
- 61.Sutherland BK, Pecanac K, LaBorde TM, et al. Good working relationships: how healthcare system proximity influences trust between healthcare workers. J Interprof Care 2022;36(3):331–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Martínez-Gómez DA, Moreno-Carrillo MA, Campillo-Soto A, et al. Reduction in diabetic amputations over 15 years in a defined Spain population. Benefits of a critical pathway approach and multidisciplinary team work. Rev Española Quimioter 2014;27(3):170–9. [PubMed] [Google Scholar]
- 63.Wrobel JS, Charns MP, Diehr P, et al. The relationship between provider coordination and diabetes-related foot outcomes. Diabetes Care 2003;26(11):3042–7. [DOI] [PubMed] [Google Scholar]
- 64.Williams DT, Powell-Chandler A, Qureshi Q, et al. Improved limb salvage for patients with vascular disease and tissue loss associated with new model of provision targeted at the diabetic foot. Diabetes Res Clin Pract 2018;135:50–7. [DOI] [PubMed] [Google Scholar]
- 65.Anichini R, Zecchini F, Cerretini I, et al. Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. Diabetes Res Clin Pract 2007;75(2):153–8. [DOI] [PubMed] [Google Scholar]
- 66.Valabhji J Rapid access to multidisciplinary diabetes foot care teams 2020;368: m773. 10.1136/bmj.m773. [DOI] [PubMed] [Google Scholar]
- 67.Leo WZ, Ge L, Chandrasekar S, et al. , DEFINITE Diabetic Foot in Primary and Tertiary Care Team. Diabetic foot in primary and tertiary (DEFINITE) care: an efficacious, synergistic and cost-effective multidisciplinary team model for diabetic foot care in Singapore. Semin Vasc Surg 2025;38(1):20–31. [DOI] [PubMed] [Google Scholar]
- 68.Malabu UH, Vangaveti VN, Goodall J, et al. Telemedical treatment of diabetic foot ulcer in rural and remote areas: a prospective single centre randomised controlled clinical trial. Diabetol Metab Syndr 2025;17(1):246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Johnson EL, Miller E. Remote patient monitoring in diabetes: how to acquire, manage, and use all of the data. Diabetes Spectr 2022;35(1):43–56. Epub 2022 Feb 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Li B Meta-analysis: total contact casts vs removable offloading. Front Endocrinol 2023;14:1178267. 10.3389/fendo.2023.1178267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Jones AW, Makanjuola A, Bray N, et al. The efficacy of custom-made offloading devices for diabetic foot ulcer prevention: a systematic review. Diabetol Metab Syndr 2024;16:172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Kosaji D, Awad MI, Katmah R, et al. Diabetic foot prevention, assessment, and management using innovative smart wearable technology: a systematic review. J Neuroeng Rehabil 2025;22:168. 10.1186/s12984-025-01695-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Misir A Artificial intelligence and machine learning in diabetic foot ulcer care: advances in diagnosis, treatment, prognosis, and novel therapeutic strategies. J Diabetes Sci Technol 2025;19322968251363632. 10.1177/19322968251363632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Gao L, Liu ZX, Wang JN. Predictive model and risk analysis for outcomes in diabetic foot ulcer using eXtreme gradient boosting algorithm and SHapley additive exPlanation. World J Diabetes 2025;16(7):104789. 10.4239/wjd.v16.i7.104789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ju HH, Momin R, Cron S, et al. A nurse-led telehealth program for diabetes foot care: feasibility and usability study. JMIR Nurs 2023;6:e40000. 10.2196/40000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Kumbhar S, Bhatia M. Advancements and best practices in diabetic foot care: a comprehensive review of global progress. Diabetes Res Clin Pract 2024;217:111845. 10.1016/j.diabres.2024.111845. Epub 2024 Sep 5. [DOI] [PubMed] [Google Scholar]
